Literature DB >> 9921604

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

M K Parmar1, V Torri, L Stewart.   

Abstract

Meta-analyses aim to provide a full and comprehensive summary of related studies which have addressed a similar question. When the studies involve time to event (survival-type) data the most appropriate statistics to use are the log hazard ratio and its variance. However, these are not always explicitly presented for each study. In this paper a number of methods of extracting estimates of these statistics in a variety of situations are presented. Use of these methods should improve the efficiency and reliability of meta-analyses of the published literature with survival-type endpoints.

Mesh:

Year:  1998        PMID: 9921604     DOI: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1747 in total

1.  Systematic reviews of evaluations of prognostic variables.

Authors:  D G Altman
Journal:  BMJ       Date:  2001-07-28

Review 2.  Oral rehydration salt solution for treating cholera: ≤ 270 mOsm/L solutions vs ≥ 310 mOsm/L solutions.

Authors:  Alfred Musekiwa; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

3.  Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.

Authors:  Jun Wang; Kainan Li; Baocheng Wang; Jingwang Bi
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

Review 4.  Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.

Authors:  Kenneth Jaaback; Nick Johnson; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 5.  Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.

Authors:  Jingru Tian; Yien Luo; Juanjuan Xiang; Jingqun Tang
Journal:  J Neurooncol       Date:  2017-07-19       Impact factor: 4.130

6.  Incorporating lag time to benefit into prevention decisions for older adults.

Authors:  Sei J Lee; Rosanne M Leipzig; Louise C Walter
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

7.  Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.

Authors:  Zuen Ren; Shijie Zhou; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  The role of SOX-2 on the survival of patients with non-small cell lung cancer.

Authors:  Wenlong Shao; Hanzhang Chen; Jianxing He
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

9.  Prognostic significance of B-cell lymphoma 2 expression in acute leukemia: A systematic review and meta-analysis.

Authors:  Yanfeng Liu; Pengcheng He; Feng Liu; Lili Shi; Huachao Zhu; Xiaoyan Cheng; Jing Zhao; Yuan Wang; Mei Zhang
Journal:  Mol Clin Oncol       Date:  2014-01-24

10.  Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Authors:  Xin-Sen Xu; Kai Qu; Chang Liu; Yue-Lang Zhang; Jun Liu; Yan-Zhou Song; Peng Zhang; Si-Nan Liu; Hu-Lin Chang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.